Open AccessWhich MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials?
Author(s) -
Joshua D. Grill,
Michelle M. Nuño,
Daniel L. Gillen
Publication year - 2019
Publication title -
alzheimer disease and associated disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 95
eISSN - 1546-4156
pISSN - 0893-0341
DOI - 10.1097/wad.0000000000000303
Subject(s) - alzheimer's disease , medicine , clinical trial , disease , degenerative disease , pediatrics
Prodromal Alzheimer disease (AD) clinical trials enroll patients with mild cognitive impairment (MCI) meeting biomarker criteria, but specific enrollment criteria vary among trials.